As we showed that MASTL depletion reduced the oncogenic properties of breast cancer cells and did not affect normal breast cells (14), we examined the antitumor activity of MKI-1 in breast cancer cells through various analyses, including: cell viability, clonogenic, and mammosphere formation assays, and 3D culture. The gene discussed is MASTL; the disease is breast carcinoma.